7 completed. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 7 |
Follow Indinavir: new trials by email Literature Review of Indinavir trials Research Report on Indinavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir Indinavir/Ritonavir/Fosamprenavir - HIV Infections | Phase 4 | Completed | Emory University | 15 | 2005-07-01 | 2013-11-11 |
| HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) Lamivudine, Stavudine, Didanosine - HIV-Associated Lipodystrophy Syndrome, Cardiovascular Disease | Phase 4 | Completed | Kirby Institute | 80 | 2003-02-01 | 2012-04-12 |
| Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers Midazolam, Indinavir, Saquinavir - Healthy, HIV Infections | Phase 4 | Completed | National Institutes of Health Clinical Center (CC) | 81 | 2002-11-22 | 2017-07-02 |
| Intermittent ART in Primary HIV Infection Antiretroviral therapy plus Interleukin-2, Antiretroviral therapy alone - HIV | Phase 4 | Completed | Juan A. Arnaiz | 12 | 2000-03-01 | 2014-11-25 |
| Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia Indinavir sulfate, Lamivudine, Stavudine - HIV Infections, Hemophilia A | Phase 4 | Completed | Merck Sharp & Dohme LLC | 55 | 2005-06-24 | |
| The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection Indinavir sulfate, Lamivudine, Zidovudine - HIV Infections | Phase 4 | Completed | Merck Sharp & Dohme LLC | 200 | 2005-06-24 | |
| The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients Indinavir sulfate, Lamivudine, Stavudine - HIV Infections | Phase 4 | Completed | Merck Sharp & Dohme LLC | 540 | 2005-06-24 |
HIV Infections (6) · Cardiovascular Diseases (1) · HIV-Associated Lipodystrophy Syndrome (1) · Hemophilia A (1) · Hemophilia B (1) · Lipodystrophy (1)
Merck Sharp & Dohme LLC (3) · Emory University (1) · Juan A. Arnaiz (1) · Kirby Institute (1) · National Institutes of Health Clinical Center (CC) (1)
United States (5) · Canada (2) · Australia (1) · Spain (1)
Andrew D Carr, MD (1) · David A Cooper, MD (1) · Igho Ofotokun, MD, MSc (1) · Nicolas Wentzensen, M.D. (1)
R01HL065953 (1)